Nutrium Secures $12 Million to Enhance Corporate Nutrition Solutions

Nutrium Secures Significant Funding to Advance Corporate Nutrition
This investment reflects confidence in the corporate nutrition market's ability to manage employee health and associated costs.
Nutrium has announced that it has successfully raised $12 million in a Series A funding round, with the investment led by Vesalius Biocapital. This funding is a major milestone for Nutrium, an all-in-one corporate nutrition solution that empowers individuals by helping them create tailored meal plans, track their health progress, manage chronic conditions, reach weight goals, and ultimately lead healthier lifestyles.
Major Players Join the Funding Round
In addition to Vesalius Biocapital, the funding round saw participation from notable firms including Lince Capital, Indico Capital Partners, and Beta Capital. This investment not only validates Nutrium's business model but also solidifies the company’s position as a leader in the global corporate nutrition landscape.
Addressing Rising Healthcare Costs
The injection of capital comes at a crucial time as organizations globally face soaring healthcare costs exacerbated by rising obesity rates and the growing demand for wellness solutions. Nutrium’s platform connects users to the world’s largest network of over 350,000 registered dietitians across more than 90 countries, a vital resource for improving health outcomes.
CEO and co-founder André Santos remarks, "Nutrition has become a vital business priority for companies tackling the challenges posed by obesity and the swift uptake of GLP-1 treatments. With this new funding, we are poised to extend our reach, enhance our expert network, and deliver superior outcomes for our clients and their employees globally."
Impact of Nutrium Care on Corporate Wellness
Nutrium Care stands out as the clinically-grounded nutrition benefit, delivering measurable health and financial improvements that address escalating corporate healthcare expenses. Corporate partners working with Nutrium can typically expect a return of threefold on their investment. Additionally, they witness a five percent dip in member weight in just the first four months, a reduced need for prescription medications, and improved employee productivity.
A Cost-Effective Alternative
Furthermore, Nutrium’s programs are significantly less expensive compared to GLP-1 medications while ensuring higher retention and engagement rates. Last year, Nutrium achieved incredible 400% revenue growth, a feat that has certainly captured the attention of investors, including the recent backers in its Series A.
Expert Opinion on Nutrium’s Growth
Qasim Al-Zawawi, Principal at Vesalius Biocapital, expresses the sentiment of many investors, stating, "We are increasingly aware of the challenges that obesity presents and the vital need for effective nutrition care, which has often been overlooked. We see Nutrium as the go-to solution for employers and individuals dedicated to enhancing their overall health."
Stephan de Moraes, Managing General Partner at Indico Capital Partners, also praises Nutrium’s vision from the very beginning: "The Nutrium team has always understood the essential role nutrition plays in health and wellbeing. It’s thrilling to support their ambition and help them navigate a path to fulfill their promise of overall wellbeing, a fundamental aspect of longevity. This market is expanding rapidly and presents immense opportunities."
Future Goals and Expansion Plans
Nutrium plans to leverage its solid track record with global brands such as Wellhub, Adidas, Vodafone, and Talkspace to reinforce its presence in the United States and build strategic partnerships with health plans and consultants. This strategic approach is aimed at accelerating the scaling of nutrition care and reaching more individuals with their pioneering solutions.
About Nutrium
Founded in 2015 in Portugal, Nutrium is dedicated to reshaping how organizations approach employee health through its comprehensive corporate nutrition program, Nutrium Care. This innovative initiative provides 1:1 dietitian support, proactive digital coaching, and tracks measurable impacts on health outcomes. It is underpinned by the world’s largest network of dietitians, committing to improving millions of lives and making healthy eating practical, personalized, and evidence-based on a global scale.
Frequently Asked Questions
What is Nutrium's recent funding amount?
Nutrium recently secured $12 million in a Series A funding round led by Vesalius Biocapital.
How does Nutrium Care benefit corporations?
Nutrium Care aims to provide measurable health and financial outcomes, including weight reduction and increased productivity while helping to manage rising healthcare costs.
Which companies participated in the funding round?
In addition to Vesalius Biocapital, Lince Capital, Indico Capital Partners, and Beta Capital also took part in the funding round.
What is the significance of Nutrium's growth rate?
Nutrium experienced an impressive 400% revenue growth last year, drawing significant interest from investors and indicating strong market demand for its services.
How does Nutrium support its clients?
Nutrium provides personalized meal planning and connections to registered dietitians to enhance individual health management and chronic disease oversight.
About The Author
Contact Evelyn Baker privately here. Or send an email with ATTN: Evelyn Baker as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.